Randomized, db, Placebo-controlled 18 Week Study of BI 1356 in Type 2 Diabetic Patients With Insufficient Glycaemic Control on a Sulfonylurea Drug

This study is ongoing, but not recruiting participants.

Study NCT00819091 Information provided by Boehringer Ingelheim Pharmaceuticals

First Received: January 7, 2009 Last Updated: October 12, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	January 2010 (Final data collection date for primary outcome measure)